» Articles » PMID: 30425655

Nuclear Envelope Transmembrane Proteins in Myotonic Dystrophy Type 1

Overview
Journal Front Physiol
Date 2018 Nov 15
PMID 30425655
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Myotonic dystrophy type 1 (DM1) is a multisystemic disorder with predominant myotonia and muscular dystrophy which is caused by CTG-repeat expansions in the gene. These repeat expansions are transcribed and the resulting mRNA accumulates RNA-binding proteins involved in splicing, resulting in a general splicing defect. We observed nuclear envelope (NE) alterations in DM1 primary myoblasts. These included invaginations of the NE as well as an altered composition of the nuclear lamina. Specifically, we investigated NE transmembrane proteins (NETs) in DM1 primary myoblasts, staining to determine if their distribution was altered compared to controls and if this could contribute to these structural defects. We also tested the expression of these NETs in muscle and how localization changes in the DM1 primary myoblasts undergoing differentiation in vitro to myotubes. We found no changes in the localization of the tested NETs, but most tended to exhibit reduced expression with increasing -repeat length. Nonetheless, the DM1 patient expression range was within the expression range of the controls. Additionally, we found a down-regulation of the possible nesprin 1 giant isoform in DM1 primary myoblasts which could contribute to the increased NE invaginations. Thus, nesprin 1 may be an interesting target for further investigation in DM1 disease pathology.

Citing Articles

Net39 protects muscle nuclei from mechanical stress during the pathogenesis of Emery-Dreifuss muscular dystrophy.

Zhang Y, Ramirez-Martinez A, Chen K, McAnally J, Cai C, Durbacz M J Clin Invest. 2023; 133(13).

PMID: 37395273 PMC: 10313361. DOI: 10.1172/JCI163333.


Automatic Text-Mining Approach to Identify Molecular Target Candidates Associated with Metabolic Processes for Myotonic Dystrophy Type 1.

Kuntawala D, Martins F, Vitorino R, Rebelo S Int J Environ Res Public Health. 2023; 20(3).

PMID: 36767649 PMC: 9915907. DOI: 10.3390/ijerph20032283.


Nuclear envelope transmembrane proteins involved in genome organization are misregulated in myotonic dystrophy type 1 muscle.

Todorow V, Hintze S, Schoser B, Meinke P Front Cell Dev Biol. 2023; 10:1007331.

PMID: 36699009 PMC: 9868253. DOI: 10.3389/fcell.2022.1007331.


Nuclear Envelope Alterations in Myotonic Dystrophy Type 1 Patient-Derived Fibroblasts.

Viegas D, Pereira C, Martins F, Mateus T, da Cruz E Silva O, Herdeiro M Int J Mol Sci. 2022; 23(1).

PMID: 35008948 PMC: 8745202. DOI: 10.3390/ijms23010522.


Transcriptome Analysis in a Primary Human Muscle Cell Differentiation Model for Myotonic Dystrophy Type 1.

Todorow V, Hintze S, Kerr A, Hehr A, Schoser B, Meinke P Int J Mol Sci. 2021; 22(16).

PMID: 34445314 PMC: 8395314. DOI: 10.3390/ijms22168607.


References
1.
Lu W, Schneider M, Neumann S, Jaeger V, Taranum S, Munck M . Nesprin interchain associations control nuclear size. Cell Mol Life Sci. 2012; 69(20):3493-509. PMC: 11114684. DOI: 10.1007/s00018-012-1034-1. View

2.
Holmer L, Worman H . Inner nuclear membrane proteins: functions and targeting. Cell Mol Life Sci. 2002; 58(12-13):1741-7. PMC: 11337314. DOI: 10.1007/PL00000813. View

3.
De Antonio M, Dogan C, Hamroun D, Mati M, Zerrouki S, Eymard B . Unravelling the myotonic dystrophy type 1 clinical spectrum: A systematic registry-based study with implications for disease classification. Rev Neurol (Paris). 2016; 172(10):572-580. DOI: 10.1016/j.neurol.2016.08.003. View

4.
Korfali N, Wilkie G, Swanson S, Srsen V, de Las Heras J, Batrakou D . The nuclear envelope proteome differs notably between tissues. Nucleus. 2012; 3(6):552-64. PMC: 3515538. DOI: 10.4161/nucl.22257. View

5.
Furling D, Coiffier L, Mouly V, Barbet J, St Guily J, Taneja K . Defective satellite cells in congenital myotonic dystrophy. Hum Mol Genet. 2001; 10(19):2079-87. DOI: 10.1093/hmg/10.19.2079. View